메뉴 건너뛰기




Volumn 286, Issue 4, 2011, Pages 2707-2718

Converting the highly amyloidogenic human calcitonin into a powerful fibril inhibitor by three-dimensional structure homology with a non-amyloidogenic analogue

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOIDOGENESIS; AMYLOIDOGENIC PEPTIDES; FIBRIL FORMATION; HUMAN CALCITONIN; HUMAN DISEASE; INTRACELLULAR CAMP; IRREVERSIBLE AGGREGATION; NEW FORMS; NEW STRATEGY; RESISTANT MUTANTS; SALMON CALCITONIN; SOLUTION STRUCTURES; STRUCTURAL HOMOLOGY; THERAPEUTIC ACTIVITY; THREE-DIMENSIONAL STRUCTURE;

EID: 78951482692     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M110.182014     Document Type: Article
Times cited : (31)

References (74)
  • 24
    • 78951482795 scopus 로고    scopus 로고
    • Patent RM2007A000481, 09/17/ 2007, Italy
    • Andreotti, G., and Motta, A. (2007) Patent RM2007A000481, 09/17/ 2007, Italy
    • (2007)
    • Andreotti, G.1    Motta, A.2
  • 57
    • 1342272122 scopus 로고    scopus 로고
    • (Bock, G. R., and Goodel, J. A., eds) John Wiley and Sons, Inc., Chichester, UK
    • Arvinte, T. (1996) in Ciba Foundation Symposium (Bock, G. R., and Goodel, J. A., eds) Vol. 199, pp. 90-97, John Wiley and Sons, Inc., Chichester, UK
    • (1996) Ciba Foundation Symposium , vol.199 , pp. 90-97
    • Arvinte, T.1
  • 62
    • 0036135139 scopus 로고    scopus 로고
    • Gazit, E. (2002) FASEB J. 16, 77-83
    • (2002) FASEB J. , vol.16 , pp. 77-83
    • Gazit, E.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.